Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by technology • Immunoassays • Molecular diagnostics PART 07: Market segmentation by product • Clostridium difficile • Clostridium perfringens • Clostridium botulinum • Clostridium tetani • Clostridium sordellii PART 08: Market segmentation by end-user • Hospitals • Independent laboratories • Physicians' clinics PART 09: Geographical segmentation • Market overview • Americas • EMEA • APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Market challenges PART 12: Market trends • Technological advancements • Increasing focus on reducing nosocomial infections • Growing popularity of portable POCT products PART 13: Vendor landscape • Competitive landscape PART 14: Key vendor analysis • Abbott • Beckman Coulter • Olympus Corporation • Siemens Healthineers • F. Hoffmann-La Roche • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global Clostridium diagnostics market: Overview Exhibit 02: Human pathogenic Clostridium species Exhibit 03: Global Clostridium diagnostics market 2016-2021 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global Clostridium diagnostics market by technology 2016 (%) Exhibit 06: Global immunoassays market: Overview Exhibit 07: Global Clostridium diagnostics market by immunoassays 2016-2021 ($ millions) Exhibit 08: Diagnostic tests for Clostridium difficile Exhibit 09: Global molecular diagnostics market: Overview Exhibit 10: Global Clostridium diagnostics market by molecular diagnostics 2016-2021 ($ millions) Exhibit 11: FDA-approved nucleic acid-based tests for diagnosis of Clostridium difficile Exhibit 12: Global Clostridium difficile diagnostics market 2016-2021 ($ millions) Exhibit 13: Global Clostridium perfringens diagnostics market 2016-2021 ($ millions) Exhibit 14: Global Clostridium botulinum diagnostics market 2016-2021 ($ millions) Exhibit 15: Global Clostridium tetani diagnostics market 2016-2021 ($ millions) Exhibit 16: Global Clostridium sordellii diagnostics market 2016-2021 ($ millions) Exhibit 17: Global Clostridium diagnostics market by geography 2016 (%) Exhibit 18: Global Clostridium diagnostics market by geography 2021 (%) Exhibit 19: Global Clostridium diagnostics market by geography 2016-2021 ($ millions) Exhibit 20: Global Clostridium diagnostics market by geography 2016-2021 (%) Exhibit 21: Clostridium diagnostics market in Americas ($ millions) Exhibit 22: Clostridium diagnostics market in US: Overview Exhibit 23: Clostridium diagnostics market in EMEA ($ millions) Exhibit 24: Clostridium diagnostics market in Germany: Overview Exhibit 25: Clostridium diagnostics market in APAC ($ millions) Exhibit 26: Clostridium diagnostics market in Japan: Overview Exhibit 27: Abbott: Key highlights Exhibit 28: Abbott: Strength assessment Exhibit 29: Abbott: Strategy assessment Exhibit 30: Abbott: Opportunity assessment Exhibit 31: Beckman Coulter: Key highlights Exhibit 32: Beckman Coulter: Strength assessment Exhibit 33: Beckman Coulter: Strategy assessment Exhibit 34: Beckman Coulter: Opportunity assessment Exhibit 35: Olympus Corporation: Key highlights Exhibit 36: Olympus Corporation: Strength assessment Exhibit 37: Olympus Corporation: Strategy assessment Exhibit 38: Olympus Corporation: Opportunity assessment Exhibit 39: Siemens Healthineers: Key highlights Exhibit 40: Siemens Healthineers: Strength assessment Exhibit 41: Siemens Healthineers: Strategy assessment Exhibit 42: Siemens Healthineers: Opportunity assessment Exhibit 43: F. Hoffmann-La Roche: Key highlights Exhibit 44: F. Hoffmann-La Roche: Strength assessment Exhibit 45: F. Hoffmann-La Roche: Strategy assessment Exhibit 46: F. Hoffmann-La Roche: Opportunity assessment

Abbott, Beckman Coulter, Olympus, Siemens Healthineers, F. Hoffmann-La Roche, BD, bioMerieux, Chrono-log Corporation, Corgenix, Diazyme Laboratories, FUJIREBIO DIAGNOSTICS, Hologic, QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific.